In this article, we are going to take a look at where Akero Therapeutics Inc (NASDAQ:AKRO) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 ...

In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best booming stocks to invest in now. The U.S. stock market closed on a downbeat ...

In this article, we are going to take a look at where Akero Therapeutics Inc (NASDAQ:AKRO) stands against the other healthcare stocks. The healthcare sector is staging a comeback so far in 2025 after ...

We recently compiled a list of the 12 Best Booming Stocks to Invest in Now. In this article, we are going to take a look at where Akero Therapeutics, Inc. (NASDAQ:AKRO) stands against other best ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Catriona Yale, the Chief Development Officer of $AKRO, sold 14,467 shares of the company on 01-27-2025 for an estimated $809,428. We received data on the trade from a ...

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week data from a mid-stage study of its lead product candidate, efruxifermin ...

J.P. Morgan analyst Eric Joseph maintained a Buy rating on Akero Therapeutics (AKRO – Research Report) on January 27 and set a price target of $73.00. The company’s shares closed yesterday at ...